Lord, Abbett & Co’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-724,625
| Closed | -$37.1M | – | 541 |
|
2024
Q4 | $37.1M | Sell |
724,625
-21,493
| -3% | -$1.1M | 0.12% | 219 |
|
2024
Q3 | $38.1M | Sell |
746,118
-141,803
| -16% | -$7.25M | 0.12% | 205 |
|
2024
Q2 | $39.8M | Sell |
887,921
-76,647
| -8% | -$3.43M | 0.13% | 206 |
|
2024
Q1 | $45.2M | Buy |
964,568
+187,280
| +24% | +$8.77M | 0.15% | 192 |
|
2023
Q4 | $27.7M | Buy |
+777,288
| New | +$27.7M | 0.1% | 272 |
|